Devyser appoints Camilla Wiberg as Chief HR Officer
On September 1, Camilla Wiberg will take up the newly established position as Chief HR Officer (CHRO) and become a member of the Devyser group management. In Devyser’s current growth phase, HR is an important, central function needed to support and develop the organization. Camilla will lead this work in her new role.
Camilla Wiberg has nearly 20 years’ experience working in strategic and operational HR in a number of industries. For the past five years she has run her own company, where she has held various positions including interim HR Manager and organization development roles. She previously worked in HR at companies such as Orkla Care AB and Avanade.
“Camilla has acted as Devyser’s HR Manager on a consultancy basis since autumn 2020 and knows our company and our employees well. We are very pleased that she has chosen to continue to work with us in this new role and we will benefit greatly from her extensive experience working with global growth companies”, says Fredrik Alpsten, Devyser’s CEO.
Following Camilla Wiberg’s appointment, the company’s group management team will comprise Fredrik Alpsten, CEO, Sabina Berlin, CFO, Theis Kipling, CCO, Göran Rydin, COO, Ulf Klangby, Deputy CEO, and Camilla Wiberg, CHRO.
This information was submitted for publication by the contact persons below on 18 August 2022 at 10.30 am CET.
For more information, please contact:
Fredrik Alpsten, CEO
Email: [email protected]
Tel: +46 706 673 106
Sabina Berlin, CFO
Email: [email protected]
Tel: +46 739 519 502
About Devyser Diagnostics AB (publ)
Devyser develops, produces and sells genetic testing kits to laboratories in more than 45 countries. The products are used for advanced DNA testing within the oncology, transplant and hereditary disease fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up. Devyser’s products simplify complex genetic testing processes, improve sample throughput, minimize hands-on time and deliver rapid results. The company was founded in 2004 and is based in Stockholm, Sweden.
Devyser’s shares are listed on the Nasdaq First North Growth Market Stockholm (ticker: DVYSR). The company’s Certified Adviser is Redeye AB. For more information, visit www.devyser.com.